Carlos Lopez-Gomez Selected Research

Therapeutics

10/2021

Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Lopez-Gomez Research Topics

Disease

2	Mitochondrial Myopathies (Mitochondrial Myopathy) 10/2021 - 08/2019
1	Non-alcoholic Fatty Liver Disease 12/2021
1	Insulin Resistance 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2021
1	Multiple Sclerosis 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Muscular Diseases (Myopathy) 05/2017

Drug/Important Bio-Agent (IBA)

2	Mitochondrial DNA (mtDNA)IBA 08/2019 - 05/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021
1	HLA-DR Antigens (HLA-DR)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	thymidine kinase 2IBA 10/2021
1	ThymidineIBA 10/2021
1	pyrimidineIBA 10/2021
1	DeoxycytidineIBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	CeramidesIBA 01/2019

Therapy/Procedure

1	Therapeutics 10/2021